Taro Provides Results for September 30, 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St falls as tech earnings spark AI spending worries; oil hits $100
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
- Dollar hits new 40-year high versus yen, euro lower after ECB decision
Taro Pharma (TARO) Misses Q2 EPS by 36c, Approves Special Dividend
November 5, 2018 4:09 PM ESTTaro Pharma (NYSE: TARO) reported Q2 EPS of $1.60, $0.36 worse than the analyst estimate of $1.96. Revenue for the quarter came in at $159 million versus the consensus estimate of $167.41 million.
Special Dividend Approved by Board of Directors
The Taro Board of Directors has declared a $500 million (or... More
